CD160 Polyclonal Antibody, Cy5 Conjugated
Référence bs-2526R-Cy5
Conditionnement : 100uL
Marque : Bioss
Applications
Reactivity
Predicted Reactivity
| Overview | |
| Catalog # | bs-2526R-Cy5 |
| Product Name | CD160 Polyclonal Antibody, Cy5 Conjugated |
| Applications | WB, FCM, IF(IHC-P) |
| Reactivity | Human |
| Predicted Reactivity | Mouse, Rat, Dog |
| Specifications | |
| Conjugation | Cy5 |
| Host | Rabbit |
| Source | KLH conjugated synthetic peptide derived from human CD160 |
| Clonality | Polyclonal |
| Isotype | IgG |
| Concentration | 1ug/ul |
| Purification | Purified by Protein A. |
| Storage Buffer | Aqueous buffered solution containing 0.01M TBS (pH 7.4) with 1% BSA, 0.02% Proclin300 and 50% Glycerol. |
| Storage Condition | Store at -20C. Aliquot into multiple vials to avoid repeated freeze-thaw cycles. |
| Target | |
| Gene ID | 11126 |
| Swiss Prot | O95971 |
| Subcellular location | Cell membrane |
| Synonyms | NK1; BY55; NK28; CD160 antigen; Natural killer cell receptor BY55; CD160 |
| Background | CD160, a 27 kDa glycoprotein, was initially identified with the monoclonal antibody BY55. Its expression is tightly associated with peripheral blood NK cells and CD8 T lymphocytes with cytolytic effector activity. The cDNA sequence of CD160 predicts a cysteine rich, glycosylphosphatidylinositol anchored protein of 181 amino acids with a single Ig-like domain weakly homologous to KIR2DL4 molecule. |
| Application Dilution | |
| WB | 1:300-5000 |
| FCM | 1:20-100 |
| IF(IHC-P) | 1:50-200 |

